In particular, an inverse correlation between PLCβ1 gene expression and glioma pathological grade has been highlighted, suggesting PLCβ1 as a potential prognostic factor and a potential novel signature gene for the classification of HGG. The gene discussed is PLCB1; the disease is central nervous system cancer.